CEO Kurtz Leaving TorreyPines Therapeutics

Aug 11, 2008 (financialwire.net via COMTEX) -- TPTX | Quote | Chart | News | PowerRating -- August 11, 2008 (FinancialWire) TorreyPines Therapeutics, Inc. (NASDAQ: TPTX | Quote | Chart | News | PowerRating) (Current Market Cap: US$14.33 Mil.) said that Neil Kurtz is resigning as president, chief executive officer and a director of the company effective as of August 31. Evelyn Graham, who has served as the company's chief operating officer since 2006, has been named as acting CEO.

Graham joined TorreyPines in 2004 as vice president of development. She was then promoted to VP of corporate development in 2005 and COO in 2006. Prior to joining TorreyPines, she was executive director of development operations at Purdue Pharma from 2000 to 2003.

La Jolla, California-based TorreyPines Therapeutics is a biopharmaceutical company focused on the research, development and commercialization of small molecule compounds. The company's goal is to develop product candidates capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity and rigidity, xerostomia and cognitive disorders.

FinancialWire" is a fully independent, proprietary news wire service of Investrend Information (a division of Investrend Communications, Inc.). FinancialWire" news is written by professional journalists, dedicated to pure journalistic standards. FinancialWire" does not receive or accept any compensation from any individual or subject company (or representative thereof) for its news or opinions. All FinancialWire" news is available at http://www.financialwire.net . Please address any inquiries to feedback@financialwire.net .

Free annual reports for companies mentioned in the news are available at http://investrend.ar.wilink.com/?level=279 .

http://www.financialwire.net

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index